News from the Research CentersCENTER FOR PHARMACEUTICAL BIOTECHNOLOGY AND NANOMEDICINE
The NIH-funded Northeastern University Center for Translational Cancer Nanomedicine (CTCN) was established within CPBN in September 2010 as part of Phase 2 of the National Cancer Institute's Alliance for Nanotechnology in Cancer program with collaborations at Beth Israel Deaconess Hospital; Harvard Medical School; Tufts University, Auburn University, and Nemucore Medical Innovations, Inc. The CTCN will utilize the support and facilities of the NU-based Center for High-rate Nanomanufacturing.
Northeastern University CTCN is one of the only nine Centers of Cancer Nanotechnology Excellence (CCNE) across the country that has been awarded with a five-year, $13.5 million grant from the NCI Alliance in an open nationwide competition.
Northeastern University researchers are well-represented in CTCN. Besides Professor Vladimir Torchilin, who is the Principal Investigator of CTCN and Project #1, among other projects and core leaders are Professor Mansoor Amiji, Dr. Srinivas Sridhar and Dr. Craig Ferris.
In December 2010 the Essential Science Indicators database of Thompson Reuters ranked Professor Vladimir Torchilin number 2 among 10 top scientists in pharmacology and toxicology for the period January 1, 2000 through August 31, 2010.
Find full story at http://www.timeshighereducation.co.uk/story.asp?storycode=414533
On April 21, 2011 Dr. Vladimir Torchilin received an Excellence in Research and Creative Activity Award at Northeastern's Academic Honors Convocation.
Tao Wang, doctoral candidate received in 2011 three awards:
• Biotechnology Graduate Student Symposium Awards at the 2011 AAPS National Biotechnology Conference based on the most outstanding contributions and excellence in the fields of pharmaceutical biotechnology through graduate research. • Outstanding Graduate Student Research Award in the Life Sciences and Technology category presented at the Academic Honors Convocation of Northeastern University.
• The John L. Neumeyer Research Achievement Award in recognition of excellence in PhD thesis research in pharmaceutical sciences.
Namita Dodwadkar, doctoral candidate received the “American Association of Indian Pharmaceutical Scientists 2011 Student Scholar Award”. Ms. Dodwadkar’s project is entitled “Delivery of Chemotherapeutic Paclitaxel (PTX) with Liposomes Modified with PEG-PE Based Mitochondriotropic Polymer Results in Enhancement of Anti-tumor Efficacy In Vitro and In Vivo.”
In the period from July 2010 to November 2011 CPBN researchers have published 25 peer reviewed articles and 16 reviews, chapters and editorials.